Business Context and Reporting Period
Company: FOCUS UNIVERSAL INC.
Filing Type: Form 8-K (Current Report)
Date of Report: April 6, 2026 (Signed April 10, 2026)
Event: Entry into a Material Definitive Agreement and Unregistered Sales of Equity Securities.
The Company announced the closing of a private placement transaction on April 8, 2026, following the execution of a Securities Purchase Agreement on April 6, 2026.
Key Financial Metrics and Transaction Details
- Total Proceeds: $4,000,000
- Securities Issued: 1,117,318 Common Units
- Purchase Price: $3.58 per Common Unit (or $3.57999 per Pre-Funded Unit)
- Placement Agent Commission: 7% of aggregate gross proceeds
- Placement Agent: Aegis Capital Corp.
Unit Composition: Each Common Unit consists of:
- One (1) share of common stock (or one Pre-Funded Warrant exercisable at $0.00001).
- One (1) Series A PIPE Common Warrant (Exercise Price: $3.33; Expiration: 24 months).
- One (1) Series B PIPE Common Warrant (Exercise Price: $3.33; Expiration: 60 months).
Note: This filing does not provide revenue, profit, cash flow, margin, or debt metrics for the Company's operations.
Material Changes and Transaction Terms
The primary material change is the capital raise via private placement. Key terms include:
- Beneficial Ownership Limitation: The Investor is restricted from exercising warrants if it would result in ownership exceeding 4.99% (or 9.99% at the Investor's election) of outstanding common stock. This limit can be adjusted with 61 days' prior notice.
- Registration Rights: The Company must file a registration statement for the resale of warrant shares within 15 calendar days of the transaction closing.
- Exercise Mechanics: Warrants are exercisable immediately. Cashless exercise is permitted if no effective registration statement is in place at the time of exercise.
Guidance, Outlook, and Risks
Management Commentary: The filing references press releases regarding the pricing and closing of the transaction but does not contain forward-looking guidance, operational outlook, or management commentary on future performance.
Risks and Contingencies:
- Unregistered Securities: The Common Units were issued pursuant to Section 4(a)(2) of the Securities Act and are not registered; they cannot be offered or sold in the U.S. absent registration or an exemption.
- Dilution: The issuance of 1,117,318 units and associated warrants may result in dilution to existing shareholders.
Investor Verification Checklist
- Verify the final closing date and total proceeds received ($4,000,000) via the press release dated April 8, 2026 (Exhibit 99.2).
- Confirm the filing of the registration statement for warrant shares within the required 15-day window post-closing.
- Review the specific identity of the "Investor" and any potential conflicts of interest, as the filing refers to them generally as a "private accredited investor."
- Assess the impact of the 7% placement fee and reimbursed legal expenses on net proceeds.
- Monitor the Company's ability to maintain Nasdaq listing requirements following the issuance of new shares and warrants.